{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:40:56Z","timestamp":1791819656980,"version":"4.3.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41575-025-01085-5","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T10:33:55Z","timestamp":1750070035000},"page":"669-671","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The IDEAL framework for machine perfusion in liver transplantation"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8600-0479","authenticated-orcid":false,"given":"Otto B.","family":"van Leeuwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-3387","authenticated-orcid":false,"given":"David","family":"Nasralla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8702-3744","authenticated-orcid":false,"given":"Carlo D. L.","family":"Ceresa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3016-604X","authenticated-orcid":false,"given":"Philipp","family":"Dutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-9685","authenticated-orcid":false,"given":"Peter J.","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-920X","authenticated-orcid":false,"given":"Gabriel C.","family":"Oniscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0538-734X","authenticated-orcid":false,"given":"Robert J.","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-5917","authenticated-orcid":false,"given":"Vincent E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the COPE 2 Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia Lo","family":"Faro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian P. J.","family":"Alwayn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia J.","family":"Hessheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantino","family":"Fondevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethard","family":"Monbaliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"\u00d6linger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal Dag","family":"Line","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"1085_CR1","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","volume":"374","author":"P McCulloch","year":"2009","unstructured":"McCulloch, P. et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 374, 1105\u20131112 (2009).","journal-title":"Lancet"},{"key":"1085_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1111\/j.1600-6143.2007.01846.x","volume":"7","author":"C Fondevila","year":"2007","unstructured":"Fondevila, C. et al. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am. J. Transplant. 7, 1849\u20131855 (2007).","journal-title":"Am. J. Transplant."},{"key":"1085_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2018.12.013","volume":"70","author":"AJ Hessheimer","year":"2019","unstructured":"Hessheimer, A. J. et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J. Hepatol. 70, 658\u2013665 (2019).","journal-title":"J. Hepatol."},{"key":"1085_CR4","doi-asserted-by":"publisher","first-page":"103014","DOI":"10.1016\/j.ebiom.2020.103014","volume":"60","author":"A Schlegel","year":"2020","unstructured":"Schlegel, A. et al. Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation. eBioMedicine 60, 103014 (2020).","journal-title":"eBioMedicine"},{"key":"1085_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1600-6143.2009.02932.x","volume":"10","author":"JV Guarrera","year":"2010","unstructured":"Guarrera, J. V. et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am. J. Transplant. 10, 372\u2013381 (2010).","journal-title":"Am. J. Transplant."},{"key":"1085_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jhep.2024.06.035","volume":"82","author":"J Eden","year":"2024","unstructured":"Eden, J. et al. Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study). J. Hepatol. 82, 97\u2013106 (2024).","journal-title":"J. Hepatol."},{"key":"1085_CR7","doi-asserted-by":"publisher","first-page":"102411","DOI":"10.1016\/j.eclinm.2023.102411","volume":"68","author":"IMA Br\u00fcggenwirth","year":"2024","unstructured":"Br\u00fcggenwirth, I. M. A. et al. Prolonged hypothermic machine perfusion enables daytime liver transplantation - an IDEAL stage 2 prospective clinical trial. eClinicalMedicine 68, 102411 (2024).","journal-title":"eClinicalMedicine"},{"key":"1085_CR8","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/ajt.13708","volume":"16","author":"R Ravikumar","year":"2016","unstructured":"Ravikumar, R. et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am. J. Transplant. 16, 1779\u20131787 (2016).","journal-title":"Am. J. Transplant."},{"key":"1085_CR9","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41587-022-01354-7","volume":"40","author":"P-A Clavien","year":"2022","unstructured":"Clavien, P.-A. et al. Transplantation of a human liver following 3 days of ex situ normothermic preservation. Nat. Biotechnol. 40, 1610\u20131616 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1085_CR10","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/SLA.0000000000003540","volume":"270","author":"OB van Leeuwen","year":"2019","unstructured":"van Leeuwen, O. B. et al. Transplantation of high-risk donor livers after ex situ resuscitation and assessment using combined hypo- and normothermic machine perfusion: a prospective clinical trial. Ann. Surg. 270, 906\u2013914 (2019).","journal-title":"Ann. Surg."},{"key":"1085_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01130-8","author":"OB van Leeuwen","year":"2025","unstructured":"van Leeuwen, O. B. et al. \u2018Back-to-base\u2019 combined hypothermic and normothermic machine perfusion of human donor livers. Nat. Protoc. https:\/\/doi.org\/10.1038\/s41596-024-01130-8 (2025).","journal-title":"Nat. Protoc."},{"key":"1085_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/lt.25899","volume":"27","author":"D Ghinolfi","year":"2021","unstructured":"Ghinolfi, D. et al. Sequential use of normothermic regional and ex situ machine perfusion in donation after circulatory death liver transplant. Liver Transpl. 27, 385\u2013402 (2021).","journal-title":"Liver Transpl."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01085-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01085-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01085-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:02:25Z","timestamp":1758801745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-025-01085-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1085"],"URL":"https:\/\/doi.org\/10.1038\/s41575-025-01085-5","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"16 June 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.N. and C.D.L.C. have received consultancy income from OrganOx for assisting with the design and conduct of previous trials. P.J.F. is a co-founder and shareholder in OrganOx and received consultancy payments as non-executive chief medical officer of the company. R.J.P. has received speaker\u2019s honoraria and travel support paid to the institution by XVIVO and Aferetica. V.E.d.M. has received speaker\u2019s honoraria paid to the institution by Astellas, Chiesi and XVIVO. O.B.v.L., P.D. and G.C.O. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}